Filing Flows › ProPhase Labs (PRPH) › Who owns the stock
Who owns ProPhase Labs (PRPH) stock
3 funds reported ProPhase Labs (PRPH) shares in their latest 13F filings, worth $24K in all. The largest holder is Vanguard Group ($24K). Last quarter 0 funds added to their stakes and 0 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Group | 53,192 | $24K | new | 2025-12-31 |
| CoreCap Advisors, LLC | 10 | $0 | unchanged | 2026-09-30 |
| Farther Finance Advisors, LLC | 10 | $0 | unchanged | 2026-09-30 |
ProPhase Labs' latest quarter
ProPhase Labs, Q2 2026: revenue $1.0M (-19% year over year), operating margin -261.6%, net loss $3.1M, operating cash flow −$78K. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PRPH stock?
By the latest 13F filings: Vanguard Group ($24K); CoreCap Advisors, LLC ($0); Farther Finance Advisors, LLC ($0).
What is the short interest in PRPH?
56,673 shares were sold short at the 2026-10-15 settlement, -27.67% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.